Immunogen, Inc. (IMGN) Tops Q4 EPS by 1c; Guides FY13 Loss
Tweet Send to a Friend
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.29), $0.01 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE